O
Ordaos
Creates bespoke mini-proteins to help drug hunters deliver life-saving treatments
About Ordaos
Ordaos Bio is a pioneering startup that leverages generative AI to revolutionize the drug discovery process. Traditional methods of drug discovery are often slow, costly, and have a high failure rate. Ordaos Bio aims to address these challenges by using advanced artificial intelligence to accelerate the development of life-saving medicines. Generative AI, unlike predictive AI, can create new data and solutions, making it particularly effective in identifying potential drug candidates that might be overlooked by conventional methods.
The company primarily serves biopharmaceutical companies that are looking to streamline their drug development pipelines. By partnering with these firms, Ordaos Bio helps reduce the time and cost associated with bringing new drugs to market. This is crucial in the fight against diseases where current capabilities fall short due to financial and temporal constraints.
Operating in the healthcare and biotechnology market, Ordaos Bio's business model revolves around offering AI-driven drug discovery services. They generate revenue through partnerships and collaborations with biopharmaceutical companies, who pay for access to Ordaos Bio's cutting-edge technology and expertise. This model not only provides a steady income stream but also positions Ordaos Bio as a key player in the future of medical research.
The team at Ordaos Bio is composed of visionaries in AI, digital drug discovery, academic research, and drug development. They are committed to creating a paradigm shift in the industry, making the hidden aspects of drug discovery visible and actionable through their innovative use of generative AI.
In summary, Ordaos Bio is transforming the landscape of drug discovery by making it faster, cheaper, and more efficient through the use of generative AI. Their focus on collaboration with biopharmaceutical companies ensures that they are at the forefront of bringing new, life-saving drugs to market.
Source: Dealroom company dataAt a glance
- Founded
- 2019
- Headquarters
- New York City, United States
- Sector
- Biotech & Life Sciences
News
Open roles
Ordaos in the New York City ecosystem
The Ordaos office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed5 investors entered at this stage
VTC Ventures
Citta Ventures
Route 66 Ventures- BPBanyan Pacific
IAG Capital Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Ordaos on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ordaos on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
